Assembly Biosciences (ASMB) Other Working Capital Changes (2010 - 2026)

Assembly Biosciences' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$7.8 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 16.89% year-over-year to -$7.8 million in Q1 2026; TTM through Mar 2026 was -$34.5 million, a 103.83% decrease from a year earlier, with the FY2025 full-year figure at -$36.1 million, down 171.52% from the prior year.
• Other Working Capital Changes eased to -$7.8 million in Q1 2026 per ASMB's latest filing, from -$7.2 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $1.1 million in Q1 2025 and bottomed at -$2.6 million in Q3 2022.
• The 5-year median for Other Working Capital Changes is -$195000.0 (2025), against an average of -$312823.5.
• Across the five-year window, Other Working Capital Changes plunged 191.17% in 2025 and rose 16.89% in 2026, its largest moves.
• Year by year, Other Working Capital Changes stood at $83.6 million in 2023, then slumped by 90.58% to $7.9 million in 2024, then sank by 191.17% to -$7.2 million in 2025, then retreated by 9.12% to -$7.8 million in 2026.
• Per Business Quant, the three latest ASMB Other Working Capital Changes figures stand at -$7.8 million (Q1 2026), -$7.2 million (Q4 2025), and -$9.9 million (Q3 2025).